Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2, Randomized, Double-Blind, Multicenter, Placebo Controlled Study to Evaluate the Safety and Efficacy of Intramuscular ABP-450 (prabotulinumtoxinA) Injection for the Treatment of Cervical Dystonia

NCT04849988 is registered in ClinicalTrials.gov with AEON Biopharma, Inc. as lead sponsor.

NCT NCT04849988
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04849988 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2, Randomized, Double-Blind, Multicenter, Placebo Controlled Study to Evaluate the Safety and Efficacy of Intramuscular ABP-450 (prabotulinumtoxinA) Injection for the Treatment of Cervical Dystonia
Lead sponsor
AEON Biopharma, Inc.
Phase
Phase 2
Overall status
Completed
Start date
March 29, 2021
Completion date
July 11, 2022
Enrollment
61 (actual)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

cervical dystonia